Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: February 17, 2026
Reporting Period: Fourth Quarter and Full Fiscal Year ended December 31, 2025.
This filing serves as a notification that the Company issued a press release announcing its financial results for the specified period. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the source text provided for this summary.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms the announcement of results for the fourth quarter and full year 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the Company's earnings announcement but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and EPS figures for Q4 and Full Year 2025.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for updated forward-looking guidance or outlook statements in the press release.
- Confirm any changes in debt levels or liquidity positions mentioned in the full earnings release.